UA38056A - Method for prediction and control of effectiveness of treatment of hypertension disease - Google Patents

Method for prediction and control of effectiveness of treatment of hypertension disease

Info

Publication number
UA38056A
UA38056A UA2000052922A UA200052922A UA38056A UA 38056 A UA38056 A UA 38056A UA 2000052922 A UA2000052922 A UA 2000052922A UA 200052922 A UA200052922 A UA 200052922A UA 38056 A UA38056 A UA 38056A
Authority
UA
Ukraine
Prior art keywords
treatment
effectiveness
control
prediction
chymase
Prior art date
Application number
UA2000052922A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Любов Михайлівна Самохіна
Любовь Михайловна Самохина
Євгеній Миколайович Гольдрін
Евгений Николаевич Гольдрин
Original Assignee
Любов Михайлівна Самохіна
Любовь Михайловна Самохина
Євгеній Миколайович Гольдрін
Евгений Николаевич Гольдрин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Любов Михайлівна Самохіна, Любовь Михайловна Самохина, Євгеній Миколайович Гольдрін, Евгений Николаевич Гольдрин filed Critical Любов Михайлівна Самохіна
Priority to UA2000052922A priority Critical patent/UA38056A/en
Publication of UA38056A publication Critical patent/UA38056A/en

Links

Abstract

The invention relates to medicine and can be used in cardiology for control of prescription of adequate therapy to patients suffering on hypertension. Method for prediction and control of effectiveness of treatment of hypertension by means of bio-chemical investigation of blood in process of treatment is in following: • as bio-chemical criteria one uses activity of chymase and -1-inhibitor of proteinases ( -1-ІП) in blood serum • before treatment one predicts effectiveness of prescription of APF at activity of chymase less than 11,3 % and / or -1-ІП over 7,4 g/l g; • one makes conclusion on effectiveness of treatment at achieving normal value by activity of chymase (11,3±2,3 %).
UA2000052922A 2000-05-23 2000-05-23 Method for prediction and control of effectiveness of treatment of hypertension disease UA38056A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000052922A UA38056A (en) 2000-05-23 2000-05-23 Method for prediction and control of effectiveness of treatment of hypertension disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000052922A UA38056A (en) 2000-05-23 2000-05-23 Method for prediction and control of effectiveness of treatment of hypertension disease

Publications (1)

Publication Number Publication Date
UA38056A true UA38056A (en) 2001-05-15

Family

ID=74218035

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000052922A UA38056A (en) 2000-05-23 2000-05-23 Method for prediction and control of effectiveness of treatment of hypertension disease

Country Status (1)

Country Link
UA (1) UA38056A (en)

Similar Documents

Publication Publication Date Title
ZA989385B (en) Methods for treating hypercoagulable states or acquired protein C deficiency.
HK1070575A1 (en) Use of botulinum toxin for treating cardiovasculardiseases
DE60239612D1 (en) MONODISPERSE MIXTURES AND METHOD FOR THE TREATMENT OF DIABETES
DE69815122T2 (en) SACCHARID-CONTAINING PREPARATIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES
AU2005202257C1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
WO2002015920A3 (en) Treatment of hyperproliferative diseases
WO2003102016A3 (en) Amyloid peptide inactivating enzyme to treat alzheimer's disease
DE60137635D1 (en) USE OF ALLOPURINOL FOR THE TREATMENT OF BLOOD HIGH PRESSURE
MXPA04003773A (en) Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment.
WO2003040183A3 (en) Compounds for the diagnosis/prevention/treatment of alzheimer's disease
WO2003048775A3 (en) Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
NO20005223L (en) Composition and treatment of inflammatory bowel disease by administration of N-acetylglucosamine in the colon
UA38056A (en) Method for prediction and control of effectiveness of treatment of hypertension disease
EP1447090B8 (en) Use of hyaluronidase for preventing and treating cardiovascular diseases
WO2003032961A3 (en) Methods for preventing and treating bone loss with steroid compounds
WO2002062300A3 (en) Cholesterol-lowering agents as treatment for psychological and cognitive disorders
PT1231908E (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING A NON-BREAKING COMPOUND AND ITS USE IN THERAPY
WO2003079748A3 (en) Potentiation of cancer therapies by znf217 inhibition
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
EP1365771A4 (en) Method of treating certain eye diseases
RU2155040C2 (en) Method of treatment of patient with vibration disease
WO2000023058A3 (en) Use of an antianaerobic-bacterial or/and antiprotozoal agent (preferably metronidazole) in the manufacture of a medicament for the treatment of haemorrhoids
PT1173757E (en) Diagnosis of human kidney diseases
SU1710066A1 (en) Method for treating psoriasis
UA33164A (en) Method for prediction of course and effectiveness of treatment of complicated cardiac infarction